U
LUMO

UBS’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

UBS’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$270K Buy
1,400
+1,033
+281% +$227K ﹤0.01% 4877
2014
Q2 		$88K Buy
367
+45
+14% +$9.15K ﹤0.01% 6094
2014
Q1 		$82K Sell
322
-111
-26% -$33.9K ﹤0.01% 6243
2013
Q4 		$86K Buy
433
+189
+77% +$33.6K ﹤0.01% 6256
2013
Q3 		$41K Sell
244
-345
-59% -$55.5K ﹤0.01% 7121
2013
Q2 		$105K Buy
+589
New +$83.4K ﹤0.01% 5857

Other funds holding LUMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

UBS's LUMO Position: Q3 2014 in Review

UBS reduced its Lumos Pharma, Inc. Common Stock (LUMO) stake by 26% in Q3 2014, selling an estimated $38.7K and leaving 500 shares worth $97K. The position accounts for ﹤0.01% of the portfolio, ranked #6039.

UBS first reported a position in LUMO in Q2 2013 and has held it in 6 quarters since. The position peaked at $250K in Q4 2013. 92 funds tracked by Wall St. Rank hold LUMO as of Q3 2014.

  • UBS held 500 shares of Lumos Pharma, Inc. Common Stock worth $97K as of Q3 2014.
  • UBS sold 176 Lumos Pharma, Inc. Common Stock shares in Q3 2014, an estimated $38.7K.
  • Lumos Pharma, Inc. Common Stock made up ﹤0.01% of UBS's portfolio in Q3 2014, its #6039 holding.
  • UBS first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and has held it in 6 quarters since.
  • UBS's Lumos Pharma, Inc. Common Stock position peaked at $250K in Q4 2013.
  • 92 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.